PubMed · 1989 · 30 citations · 0 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyPediatric Clinical PharmacologyPsychopharmacologyChild PsychopharmacologyPediatric PharmacodynamicsPediatric PharmacologyPediatric PsychopharmacologyPsychopharmacology In ChildrenBlood PressureBody Core TemperatureBody TemperatureCore Body TemperatureHeart RateNaltrexone TreatmentSerial Monitoring Of Liver EnzymesSystolic Blood Pressure
The effects of acute, orally administered naltrexone (0.5, 1.0, 1.5 and 2.0 mg/kg), a potent opiate receptor antagonist, on auscultated heart rate, systolic blood pressure and axillary body temperature were investigated before and about 1 h postdrug in 5 autistic children (4-12 years of age). In addition, an electrocardiogram was recorded on each child before and about 3 h after placebo or 2.0 mg/kg of naltrexone. Finally, the serum concentrations of the liver enzymes glutamic-oxaloacetic transaminase (SGOT) and glutamic-pyruvic transaminase (SGPT) were measured 24 h following placebo or naltrexone administration. Naltrexone had no statistically significant effects on any of these measures in comparison with baseline or placebo levels. Thus, these data provide preliminary evidence for the safety of acute administration of naltrexone in children.